Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine"
- PMID: 31126921
- PMCID: PMC6535563
- DOI: 10.1128/AAC.00593-19
Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine"
Comment on
-
Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01310-18. doi: 10.1128/AAC.01310-18. Print 2019 Feb. Antimicrob Agents Chemother. 2019. PMID: 30420479 Free PMC article.
-
Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.Antimicrob Agents Chemother. 2019 May 24;63(6):e00576-19. doi: 10.1128/AAC.00576-19. Print 2019 Jun. Antimicrob Agents Chemother. 2019. PMID: 31126920 Free PMC article. No abstract available.
References
-
- Kakuda TN, Opsomer M, Timmers M, Iterbeke K, Van De Casteele T, Hillewaert V, Petrovic R, Hoetelmans RM. 2014. Pharmacokinetics of darunavir in fixed‐dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers. J Clin Pharmacol 54:949–957. doi:10.1002/jcph.290. - DOI - PubMed
-
- Castellino S, Moss L, Wagner D, Borland J, Song I, Chen S, Lou Y, Min SS, Goljer I, Culp A, Piscitelli SC, Savina PM. 2013. Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans. Antimicrob Agents Chemother 57:3536–3546. doi:10.1128/AAC.00292-13. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources